Table 4. Association with virological failure, using a logistic regression model.
| Variable | Unadjusted/ univariate model |
Adjusted/ multivariate model |
||
|---|---|---|---|---|
| OR (95% CI) | P-value | OR (95% CI) | P-value | |
| CAA+ | 0.78 (0.39–1.59) | 0.50 | 1.63 (0.53–4.95) | 0.39 |
| Female | 0.96 (0.35–2.69) | 0.94 | 0.94 (0.30–2.94) | 0.91 |
| Body mass index, per kg/m2 |
1.00 (0.85–1.18) | 1.00 | 1.05 (0.88–1.26) | 0.59 |
| Education higher vs. other* | 0.67 (0.08–5.87) | 0.71 | 0.78 (0.08–7.57) | 0.83 |
| Delay to HIV RNA testing** | 1.23 (0.42–3.66) | 0.69 | 0.98 (0.92–1.03) | 0.44 |
| WHO-stage 3/4 vs. 1/2 | 1.45 (0.54–3.89) | 0.46 | 2.34 (0.71–7.77) | 0.16 |
| MXD >1,100 cells/μl*** | 0.47 (0.14–1.54) | 0.21 | 0.47 (0.13–1.63) | 0.23 |
| Constant | 0.24 (0.00–41.88) | 0.58 | ||
*Educational attainment: lower (none/primary) vs. higher than primary
**Delay to HIV-RNA testing: median time from ART initiation to measurement of HIV RNA
***MXD: cum sum of the absolute number of eosinophils, basophils, and monocytes counts